Career & Filing History
Every role Jorey Chernett has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Jorey Chernett is a beneficial owner of more than 10% of Neuronetics, Inc. (STIM), as disclosed in SEC ownership filings. SEC records also connect Chernett to Starling Oncology, Inc. (STLN) and Airsculpt Technologies, Inc. (AIRS). Chernett has reported 36 insider filings with the SEC since 2026. The most recent filing was in August 2026.
Every role Jorey Chernett has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Neuronetics, Inc. (STIM)2 filingsStarling Oncology, Inc. (STLN)5 filingsUpdated Aug 30, 2026
Jorey Chernett is 10% Owner of Neuronetics, Inc. (STIM). 35 SEC Form 4 filings on record, most recently on 17 August 2026. Most recent open-market trade: bought $44K of STIM on 17 August 2026. Lifetime open-market purchases: $9.01M. Lifetime open-market sales: $8K. Historical track record: 4/5 stars across 38 tracked purchases.
Every recent SEC Form 4 transaction Jorey Chernett has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 38 |
| Purchases with forward-return data | 27 |
| 30-day win rate | 63% |
| 90-day win rate | 78% |
| Avg 5-day return | +4.99% |
| Avg 30-day return | +17.17% |
| Avg 90-day return | +65.97% |
| Best 30-day return |
InsiderAlpha's records for Jorey Chernett go back to 2026: 35 primary Form 4 filings, an average of 35.0 per year. The typical open-market purchase is $200K (45 buys totaling $9.01M). The largest single buy on record is $820K of STIM in 2026. Sales side: 3 recorded sales totaling $8K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Jorey Chernett files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Jorey Chernett is a corporate insider, tracked as 10% Owner of Neuronetics, Inc. (STIM). InsiderAlpha holds 35 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
7 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 45 open-market purchases ($9.01M) and 3 open-market sales ($8K) across all tracked filings.
Across 38 tracked purchases, Jorey Chernett averaged +17.2% avg 30-day return with a 63% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$STLN Starling Oncology, Inc.18.0K shares @ $5.27$95K
| +85.94% |